However, studies in several other cancer cells such as colon, hepatocellular, head and neck or oral squamous cell carcinoma indicate that GLUT1 inhibition may be considered an additional treatment option for resistant forms of cancers [48-50]. The gene discussed is SLC2A1; the disease is oral cavity squamous cell carcinoma.